Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111013884

Furosemide Related Compound B Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111013884 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
100 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-3884 100 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-3884 Supplier MilliporeSigma Supelco Supplier No. PHR1816100MG
Only null left
Add to Cart
Add to Cart

Description

Furosemide Related Compound B is an impurity of the loop diuretic drug, furosemide. Furosemide is generally used to treat fluid retention in people with heart failure, liver cirrhosis or kidney disease.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
TRUSTED_SUSTAINABILITY

Specifications

CAS 3086-91-7
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C7H7 ClN2O4 S
MDL Number MFCD03423689
Melting Point 267°C
Synonym 4-Chloro-5-sulfamoylanthranilic acid; 4-CHLORO-5- SULFAMOYLANTHRANILIC ACID
Type Certified Reference Material
Quantity 100 mg
Formula Weight 250.66
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.